Skip to main content

Security report for r-biopharm.com

R-Biopharm AG · Healthcare · Germany

High risk. 4 critical or high findings in GDPR outside view and SSL/TLS.

Security score

44/100

Risk levelHigh

0–100, higher is better. How it is calculated

R-Biopharm AG is a well-established German company specializing in clinical diagnostics, food and feed analysis, and nutrition care solutions. With over 35 years of experience and a presence in more than 120 countries, the company offers a broad portfolio of innovative products and services targeting healthcare professionals and the food industry. Their website reflects a professional and content-rich digital presence, supporting multiple languages and providing comprehensive information about their divisions and corporate responsibility initiatives. Technically, the site is built on WordPress with modern SEO and marketing tools, though performance could be improved. Security posture is currently weak due to the absence of a valid SSL certificate and HTTPS support, which is a critical risk that should be addressed immediately. Privacy compliance is strong, with clear policies and cookie consent mechanisms in place. Overall, the company demonstrates high business credibility and trustworthiness, but must prioritize securing their web infrastructure to protect users and maintain reputation.

Scanned

NIS2 and GDPR posture

GDPR outside view
18/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching r-biopharm.com

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
70
Email security
50
DNS health
85
Network security
40
GDPR outside view
18
Average
44

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates primarily in the healthcare sector, focusing on diagnostics and food safety analytics. Their business model is B2B, serving laboratories, healthcare providers, and food/feed industries. The presence of multiple specialized subdomains and a dedicated e-commerce shop indicates diversified revenue streams and a mature digital ecosystem. The company leverages partnerships, such as Nutrition Care, to expand its market reach. Their corporate social responsibility and certified quality programs enhance brand trust. The website's multilingual support and extensive product portfolio suggest a global market orientation and strong competitive positioning.

Security posture

The website currently lacks a valid SSL certificate, resulting in no HTTPS support, which is a critical security vulnerability exposing users to potential data interception and undermining trust. While some security headers like X-Frame-Options and Content-Security-Policy are present, the CSP includes unsafe directives that weaken its effectiveness. No known SSL/TLS vulnerabilities are detected, but the absence of modern TLS protocols and OCSP stapling reduces security and performance. The site uses secure forms and cookie consent mechanisms, indicating awareness of privacy requirements. Incident response and vulnerability disclosure policies are not found, suggesting areas for improvement in security governance.

Recommendations

  1. Immediately install and maintain a valid SSL/TLS certificate to enable HTTPS across the entire site.
  2. Enable TLS 1.2 or higher protocols and disable all deprecated SSL/TLS versions.
  3. Enhance Content Security Policy by removing unsafe-eval and unsafe-inline directives to mitigate XSS risks.
  4. Implement OCSP stapling and session resumption to improve SSL performance and security.
  5. Develop and publish a formal security policy and vulnerability disclosure program to improve transparency and incident response readiness.

Contact details published on the site

Addresses
Legal name
R-Biopharm AG
Technical notes

Notes

The website is built on a WordPress CMS platform using popular plugins such as Yoast SEO, WPBakery Page Builder, and Borlabs Cookie for privacy compliance. The hosting is provided by Hetzner Online GmbH, a reputable German hosting provider. The site includes modern web fonts and JavaScript libraries like jQuery. Performance metrics indicate slow loading times, possibly due to unoptimized resources or server configuration. Mobile optimization is good with responsive design elements. SEO is well implemented with meta tags, Open Graph, and structured data. Accessibility is basic but could be improved. The technical debt mainly lies in the SSL/TLS configuration and some security header weaknesses.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with r-biopharm.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review r-biopharm.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.